SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey-Reference-Cited by-同舟云学术

SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey

Published:2023-10-31 Issue:1 Volume:44 Page:81-87
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Misra Ramnath^ORCID,Bhattacharya Debdutta^ORCID,Ahmed Sakir^ORCID,Amin Sanjiv,Shobha Vineeta^ORCID,Ghosh Alakendu^ORCID,Pandya Sapan C.,Parai Debaprasad^ORCID,Padhan Prasanta^ORCID,Priyadarshini Subhadra^ORCID,Mohapatra Ipsa^ORCID,Patro A. Raj Kumar^ORCID,Mohanty Ambika Prasad^ORCID,Pati Sanghamitra^ORCID

Funder

RMRC Bhubaneswar

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-023-05489-x.pdf

Reference35 articles.

1. (2020) COVID-19 cases across India. In: MyGov.in. https://www.mygov.in/covid-19/. Accessed 18 Aug 2023

2. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed 18 Aug 2023

3. Andrews M, Areekal B, Rajesh K et al (2020) First confirmed case of COVID-19 infection in India: a case report. Indian J Med Res 151:490. https://doi.org/10.4103/ijmr.IJMR_2131_20

4. Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323:2052. https://doi.org/10.1001/jama.2020.6775

5. Strangfeld A, Schäfer M, Gianfrancesco MA et al (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis 80:930–942. https://doi.org/10.1136/annrheumdis-2020-219498